Maha Radhakrishnan, M.D.
DirectoratEntrada Therapeutics· In the 2025 proxy
Maha Radhakrishnan, M.D. is Director of Entrada Therapeutics.
Experience
- Entrada TherapeuticsPublic company · 1 yr
- Director2025 – Present · 1 yrStock in role -72%
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?